Form 4: Guardant Health Director Meghan Joyce Acquires Shares Through Stock Unit Vesting
SEC Form 4 Filing
Director Meghan Joyce of Guardant Health acquired 67 shares of common stock through the vesting of restricted stock units.
Summary
- Meghan Joyce, a director at Guardant Health, acquired 67 shares of common stock on December 4, 2024.
- The acquisition was a result of the vesting of restricted stock units.
- The price per share was $0 as it was a vesting event, not a purchase.
- Following the transaction, Ms. Joyce directly owns 7,615 shares of common stock.
- The restricted stock units vest over a three-year period, with 25% vesting on August 4, 2022, and the remaining 75% vesting monthly thereafter.
Sentiment
Score: 7
Explanation: The document reflects a routine insider transaction, which is generally neutral to positive. The vesting of shares indicates alignment of interests, which is a positive sign.
Positives
- The vesting of restricted stock units indicates a continued alignment of interests between the director and the company's performance.
- The director's increased shareholding demonstrates confidence in the company's future.
Industry Context
This is a routine filing related to insider transactions and is common for publicly traded companies. It reflects the standard practice of compensating directors with equity.
Comparison to Industry Standards
- Stock-based compensation is a common practice across the biotechnology and healthcare industries, with companies like Illumina, Exact Sciences, and Myriad Genetics also using restricted stock units as part of their compensation packages.
- The vesting schedule of the restricted stock units is typical, with a portion vesting initially and the remainder vesting over a period of time, often three to four years.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 08/04/2022 | 25% of the restricted stock units vested. |
| 12/04/2024 | Date of the reported transaction where 67 shares vested. |
| 12/05/2024 | Date the Form 4 was signed. |
Keywords
Guardant Health, Director, Meghan Joyce, Stock Units, Vesting, Share Acquisition, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.